(Q34116954)

31 July 2017

0 references

Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis (English)

1 reference

31 July 2017

0 references

0 references

hepatic encephalopathy

1 reference

1 reference

7

Poynard T

1 reference

31 July 2017

Goulenok C

1

1 reference

31 July 2017

Bernard B

2

1 reference

31 July 2017

Cadranel JF

3

1 reference

31 July 2017

Thabut D

4

1 reference

31 July 2017

Di Martino V

5

1 reference

31 July 2017

Opolon P

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

Alimentary Pharmacology & Therapeutics

31 July 2017

published in

1 reference

31 July 2017

volume

16

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

361-372

1 reference

The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01191.X

Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01191.X

First Clinical Investigation of the Benzodiazepine Antagonist Ro 15-1788 in Comatose Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01191.X

Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomised, placebo controlled multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01191.X

Meta-analyses of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01191.X

The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01191.X

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01191.X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01191.X

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01191.X

The effect of flumazenil on subclinical psychometric or neurophysiological alterations in cirrhotic patients: a double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01191.X

Methods for Assessing Hepatic Encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01191.X

Manganese and chronic hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01191.X

Diagnostic utility of flumazenil in coma with suspected poisoning: a double blind, randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01191.X

10.1046/J.1365-2036.2002.01191.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference